EUSA Pharma (Denmark) ApS: Financial statements 2021
CVR: 39055988
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
EUSA Pharma (Denmark) ApS (CVR 39055988) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 9,429,497 and a net result of DKK 482,679 compared with DKK 607,118 the year before. That is a decrease of 4.1% compared with the year before. Equity in the 2021 report amounted to DKK 1,305,255. The solvency ratio was 75.3%. The company had 5 employees in the financial year.
- Gross Profit
- DKK 9,429,497
- Profit/Loss
- DKK 482,679
- Equity
- DKK 1,305,255
- Total Assets
- DKK 1,733,279
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 9.4 mio. | 483 t. | 1.3 mio. | 5 |
| 2020 | - | 9.8 mio. | 607 t. | 823 t. | 6 |
| 2019 | - | 2.1 mio. | 228 t. | 215 t. | 3 |
Official annual report
Find more companies like EUSA Pharma (Denmark) ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
EUSA Pharma (Denmark) ApS has published its annual report for 2020. Gross profit came to DKK 9,829,410, and the net result was DKK 607,118.
As of May 25, 2021, Frank Carsten Thiel is registered as director of EUSA Pharma (Denmark) ApS.
As of May 25, 2021, Lee Scot Morley has stepped down as director of EUSA Pharma (Denmark) ApS.
About EUSA Pharma (Denmark) ApS
EUSA Pharma (Denmark) ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company has been dissolved on 19 December 2024. The company was registered under the industry Reklamebureauer. According to the 2023 annual report, the company had an average of 1 employee. In 2023, the company reported a gross profit of DKK 1,928,889 and a net result of DKK 141,012 compared with DKK 198,473 the year before. Equity in the 2023 report amounted to DKK 1,644,740.